Page 2 - Zai Labs News Today

Neither is profitable, but both could be on the verge of massive booms in revenue.

Novocure’s electrical field-producing medical device, in combination with standard drug therapies, improved overall survival in a pivotal study that enrolled patients with advanced non-small cell lung cancer. The medtech company now plans to seek regulatory approvals.

BioPharma

Zai Labs is a relative new entrant to the Chinese pharma space and has multiple approvals and a large clinical pipeline. Read more on ZLAB here.

Food and Drug Administration decisions and advisory committee verdicts slated for November were mostly positive. New molecular entity ap...

The plan relegates the CSRC to the back seat in the auditing dispute between the US and China, from the role it has held since 2016 as the collector and gatekeeper of China’s audit working papers.

ARGX earnings call for the period ending September 30, 2021.

Entasis Therapeutics, the former anti-infectives unit of AstraZeneca, has positive Phase 3 data for its lead program, an antibiotic that could address drug-resistant strains of Acinetobacter baumannii that contribute to hospital-acquired infections. The biotech plans to seek FDA approval in 2022.

Search jobs RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs SAN CARLOS, Calif.--(BUSINESS WIRE)--RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered into a research collaboration and license option agreement with Zai Labs, Inc. for the use of RubrYc’s Meso-scale Engineered Molecules (MEMs) platform, to identify monoclonal antibodi...

Search Home / Profile / Linden Thomson: It’s no surprise first vaccines came from biotech rather than large-cap pharma Linden Thomson: It’s no surprise first vaccines came from biotech rather than large-cap pharma Axa Framlington Biotech fund manager on vaccine makers thriving even after Covid In November, markets received the first hopeful phase-III trial data from a Covid-19 vaccine candidate. Pfizer is the name most closely attached to the vaccine rolled out in the U...